Carvedilol: Difference between revisions

(Text replacement - "alpha" to "α")
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==Administration==
==Administration==
*Type: Beta-blocker
*Type: [[Beta-blocker]]
*Dosage Forms:
*Dosage Forms: extended-release capsule, tablet
*Routes of Administration: oral
*Dosage Strengths: capsule, extended release: 10mg, 20mg, 40mg, 80mg; tablet: 3.125mg, 6.25mg, 12.5mg, 25mg
*Routes of Administration: PO
*Common Trade Names: Coreg
*Common Trade Names: Coreg


Line 49: Line 50:
==See Also==
==See Also==
*[[Beta-blockers]]
*[[Beta-blockers]]
*[[Beta-blocker toxicity]]
*[[Antiarrhythmics]]
*[[Antihypertensive medications]]


==References==
==References==
<references/>
<references/>
[[Category:Pharmacology]]
[[Category:Pharmacology]] [[Category:Cardiology]]

Latest revision as of 01:18, 7 March 2021

Administration

  • Type: Beta-blocker
  • Dosage Forms: extended-release capsule, tablet
  • Dosage Strengths: capsule, extended release: 10mg, 20mg, 40mg, 80mg; tablet: 3.125mg, 6.25mg, 12.5mg, 25mg
  • Routes of Administration: PO
  • Common Trade Names: Coreg

Adult Dosing

  • 3.125-50mg BID

Pediatric Dosing

Safety/efficacy not established

Special Populations

  • Pregnancy Rating: C
  • Lactation risk: Infant risk cannot be ruled out
  • Renal dosing: no adjustment
  • Hepatic dosing: contraindicated in severe liver disease

Contraindications

  • Allergy to class/drug
  • Cardiogenic shock
  • Asthma or other bronchospastic condition
  • 2nd or 3rd degree AV block, severe bradycardia, sick sinus
  • Severe hepatic impairment

Adverse Reactions

Serious

  • AV block, bradyarrhythmia, hypotension
  • SJS/TEN
  • Aplastic anemia
  • Asthma with status asthmaticus
  • Intraoperative floppy iris syndrome (?!)

Common

  • Bradyarrhythmia, hypotension
  • Peripheral edema
  • Weight gain, hyperglycemia
  • Diarrhea
  • Dizziness, fatigue
  • Erectile dysfunction

Pharmacology

  • Half-life: 7-10h
  • Metabolism: Hepatic CYP2D6
  • Excretion: Fecal/biliary

Mechanism of Action

  • Nonselective beta-blocker with α-1 blocking activity

Comments

See Also

References